Cardiometabolic comorbidities in autosomal dominant polycystic kidney disease: a 16-year retrospective cohort study

Cardiometabolic comorbidities in autosomal dominant polycystic kidney disease: a 16-year retrospective cohort study

Abstract Background Autosomal-dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease and the fourth leading cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT). Nevertheless, there is a paucity of epidemiological research examining th...

Full description

Bibliographic Details
Main Authors: Li-Chi Chen, Yi-Chi Chu, Tzongshi Lu, Hugo Y.-H. Lin, Ta-Chien Chan
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Nephrology
Subjects:
ADPKD
Cardiometabolic comorbidities
ESRD
Renal replacement therapy
All-cause mortality
Online Access:https://doi.org/10.1186/s12882-023-03382-0

Internet

https://doi.org/10.1186/s12882-023-03382-0

Similar Items